Literature DB >> 8940268

Molecular heterogeneity of late-onset forms of globoid-cell leukodystrophy.

R De Gasperi1, M A Gama Sosa, E L Sartorato, S Battistini, H MacFarlane, J F Gusella, W Krivit, E H Kolodny.   

Abstract

Globoid-cell leukodystrophy (GLD) is an autosomal recessive inherited disorder caused by the deficiency of galactocerebrosidase, the lysosomal enzyme responsible for the degradation of the myelin glycolipid galactocerebroside. Although the most common form of the disease is the classical infantile form (Krabbe disease), later-onset forms also have been described. We have analyzed the galactocerebrosidase gene in 17 patients (nine families) with late-onset GLD and in 1 patient with classical Krabbe disease. Half of the patients were heterozygous for the large gene deletion associated with the 502C-->T polymorphism, the most common mutation in infantile patients. Several novel mutations that result in deficient galactocerebrosidase activity were also identified in these patients. They include the missense mutations R63H, G95S, M101L, G268S, Y298C, and I234T; the nonsense mutation S7X; a one-base deletion (805delG); a mutation that interferes with the splicing of intron 1; and a 34-nt insertion in the RNA, caused by the aberrant splicing of intron 6. All of these genetic defects are clustered in the first 10 exons of the galactocerebrosidase gene and therefore affect the 50-kD subunit of the mature enzyme. Studies on the distribution and enzymatic activity of the polymorphic alleles 1637T/C (I546/T546) provided support for previous data that had indicated the existence of two galactocerebrosidase forms with different catalytic activities in the general population. Our data also indicate that the mutations occur preferentially in the "low activity" 1637C allele.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940268      PMCID: PMC1914878     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.

Authors:  S Akli; J Chelly; C Mezard; S Gandy; A Kahn; L Poenaru
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

2.  A 5' splice-region G----C mutation in exon 1 of the human beta-globin gene inhibits pre-mRNA splicing: a mechanism for beta+-thalassemia.

Authors:  M Vidaud; R Gattoni; J Stevenin; D Vidaud; S Amselem; J Chibani; J Rosa; M Goossens
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Two different mutations are responsible for Krabbe disease in the Druze and Moslem Arab populations in Israel.

Authors:  M A Rafi; P Luzi; J Zlotogora; D A Wenger
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

4.  Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum.

Authors:  I Satokata; K Tanaka; S Yuba; Y Okada
Journal:  Mutat Res       Date:  1992-03       Impact factor: 2.433

5.  Correction of the galactocerebrosidase deficiency in globoid cell leukodystrophy-cultured cells by SL3-3 retroviral-mediated gene transfer.

Authors:  M A Gama Sosa; R de Gasperi; S Undevia; J Yeretsian; S C Rouse; T A Lyerla; E H Kolodny
Journal:  Biochem Biophys Res Commun       Date:  1996-01-26       Impact factor: 3.575

6.  Molecular defects in Krabbe disease.

Authors:  N Tatsumi; K Inui; N Sakai; H Fukushima; J Nishimoto; I Yanagihara; T Nishigaki; H Tsukamoto; L Fu; M Taniike
Journal:  Hum Mol Genet       Date:  1995-10       Impact factor: 6.150

7.  Substitution of alanine543 with a threonine residue at the carboxy terminal end of the beta-chain is associated with thermolabile hexosaminidase B in a Jewish family of Oriental ancestry.

Authors:  R De Gasperi; M A Gama Sosa; E E Grebner; D Mansfield; S Battistini; E L Sartorato; S S Raghavan; J G Davis; E H Kolodny
Journal:  Biochem Mol Med       Date:  1995-10

8.  A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease.

Authors:  M A Rafi; P Luzi; Y Q Chen; D A Wenger
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

9.  Krabbe disease locus mapped to chromosome 14 by genetic linkage.

Authors:  J Zlotogora; S Chakraborty; R G Knowlton; D A Wenger
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

10.  A base substitution in the exon of a collagen gene causes alternative splicing and generates a structurally abnormal polypeptide in a patient with Ehlers-Danlos syndrome type VII.

Authors:  D Weil; M D'Alessio; F Ramirez; W de Wet; W G Cole; D Chan; J F Bateman
Journal:  EMBO J       Date:  1989-06       Impact factor: 11.598

View more
  28 in total

1.  Globoid cell leukodystrophy (Krabbe disease): normal umbilical cord blood galactocerebrosidase activity and polymorphic mutations.

Authors:  S Raghavan; B Zeng; P A Torres; G M Pastores; E H Kolodny; J Kurtzberg; W Krivit
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 2.  Newborn screening for Krabbe's disease.

Authors:  Joseph J Orsini; Carlos A Saavedra-Matiz; Michael H Gelb; Michele Caggana
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.

Authors:  Dae Song Jang; Wenjuan Ye; Tian Guimei; Melani Solomon; Noel Southall; Xin Hu; Juan Marugan; Marc Ferrer; Gustavo H B Maegawa
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 4.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

5.  Beyond Krabbe's disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathies.

Authors:  Michael S Marshall; Ernesto R Bongarzone
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 6.  Krabbe Disease in the Arab World.

Authors:  Hatem Zayed
Journal:  J Pediatr Genet       Date:  2015-03

Review 7.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

8.  Structural snapshots illustrate the catalytic cycle of β-galactocerebrosidase, the defective enzyme in Krabbe disease.

Authors:  Chris H Hill; Stephen C Graham; Randy J Read; Janet E Deane
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

9.  Two Cases of Female Chinese Adult-Onset Krabbe Disease with One Novel Mutation and a Review of Literature.

Authors:  Chengyi Zhang; Zheng Liu; Huiqing Dong
Journal:  J Mol Neurosci       Date:  2020-11-14       Impact factor: 3.444

Review 10.  Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases.

Authors:  William Krivit
Journal:  Springer Semin Immunopathol       Date:  2004-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.